Login

Cart

Your cart is empty

News

RSS feed
Hhemp.co Expands its Cannabinoid Lineup With CBGa and CBDa Accelerated by COVID-19 Study Findings

Hhemp.co Expands its Cannabinoid Lineup With CBGa and CBDa Accelerated by COVID-19 Study Findings

Hhemp.co Expands its Cannabinoid Lineup With CBGa and CBDa Accelerated by COVID-19 Study Findings

Hhemp.co Expands its Cannabinoid Lineup With CBGa and CBDa Accelerated by COVID-19 Study Findings

Hhemp.co, the leading CBD:CBG product manufacturing and distribution company, is elevating its world-class line of products by introducing cannabinoids CBGa and CBDa. Please click here to read the ...

Read more
Recent Findings in COVID-19 Studies Accelerate Hhemp.co’s Plan to Launch New CBDa and CBGa Product Line

Recent Findings in COVID-19 Studies Accelerate Hhemp.co’s Plan to Launch New CBDa and CBGa Product Line

HAYWARD, CA, UNITED STATES, February 8, 2022 /EINPresswire.com/ -- Premium hemp brand, Hhemp.co (“Hhemp.co” or “The Company”) is proud to announce its role in helping facilitate extraction for the ...

Read more

Products listed contains a total delta-9 tetrahydrocannabinol concentration that does not exceed 0.30% on a dry-weight basis. The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease. None of the products contain any percentage of nictoine or tobacco. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product.